Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew A Fuller

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Pharmacotherapy|August 19, 2003
Comparative study of the development of diabetes mellitus in patients taking risperidone and olanzapineMatthew A Fuller, Kenneth M Shermock, Michelle Secic, et al.
The Annals of Pharmacotherapy|July 26, 2012
Lurasidone: an atypical antipsychotic for schizophreniaVineeta Risbood, Jennifer R Lee, Jennifer Roche-Desilets, et al.
Expert Review of Neurotherapeutics|April 28, 2005
Risperidone for bipolar disordersMartha Sajatovic, Subramoniam Madhusoodanan, Matthew A Fuller, et al.
Clinical Pharmacokinetics|November 9, 2004
Pharmacokinetics of quetiapine in elderly patients with selected psychotic disordersGeorge E Jaskiw, Per T Thyrum, Matthew A Fuller, et al.
Psychiatric Services (Washington, D.C.)|July 4, 2002
Service use and costs among VA patients with schizophrenia taking risperidone or olanzapineMatthew A Fuller, Kenneth M Shermock, Michelle Secic, et al.
The Mental Health Clinician|June 30, 2018
Evaluation of adherence in patients prescribed long-acting injectable antipsychotics: A comparison of biweekly versus monthly administered neurolepticsChelsea N Carr, Colleen P Hall, Jennifer E Roche-Desilets, et al.
The Journal of the Association of Nurses in AIDS Care : JANAC|December 6, 2011
Pilot study to assess subjective and objective reporting of potential adverse drug reactions in older versus younger HIV-infected patients using antiretroviral therapyAmy A Hirsch, Anita Compan, Renée H Lawrence, et al.
The Journal of Clinical Psychiatry|May 10, 2002
Phenylpropanolamine appears not to promote weight loss in patients with schizophrenia who have gained weight during clozapine treatmentMary C Borovicka, Matthew A Fuller, P Eric Konicki, et al.
CNS Spectrums|July 27, 2005
Reassessing carbamazepine in the treatment of bipolar disorder: clinical implications of new dataHagop S Akiskal, Matthew A Fuller, Robert M A Hirschfeld, et al.
The Primary Care Companion for CNS Disorders|May 17, 2021
Development of Insomnia Associated With Different Formulations of BupropionKamal Gandotra, George E Jaskiw, Scott G Williams, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Pharmacotherapy|August 19, 2003
Comparative study of the development of diabetes mellitus in patients taking risperidone and olanzapineMatthew A Fuller, Kenneth M Shermock, Michelle Secic, et al.
The Annals of Pharmacotherapy|July 26, 2012
Lurasidone: an atypical antipsychotic for schizophreniaVineeta Risbood, Jennifer R Lee, Jennifer Roche-Desilets, et al.
Expert Review of Neurotherapeutics|April 28, 2005
Risperidone for bipolar disordersMartha Sajatovic, Subramoniam Madhusoodanan, Matthew A Fuller, et al.
Clinical Pharmacokinetics|November 9, 2004
Pharmacokinetics of quetiapine in elderly patients with selected psychotic disordersGeorge E Jaskiw, Per T Thyrum, Matthew A Fuller, et al.
Psychiatric Services (Washington, D.C.)|July 4, 2002
Service use and costs among VA patients with schizophrenia taking risperidone or olanzapineMatthew A Fuller, Kenneth M Shermock, Michelle Secic, et al.
The Mental Health Clinician|June 30, 2018
Evaluation of adherence in patients prescribed long-acting injectable antipsychotics: A comparison of biweekly versus monthly administered neurolepticsChelsea N Carr, Colleen P Hall, Jennifer E Roche-Desilets, et al.
The Journal of the Association of Nurses in AIDS Care : JANAC|December 6, 2011
Pilot study to assess subjective and objective reporting of potential adverse drug reactions in older versus younger HIV-infected patients using antiretroviral therapyAmy A Hirsch, Anita Compan, Renée H Lawrence, et al.
The Journal of Clinical Psychiatry|May 10, 2002
Phenylpropanolamine appears not to promote weight loss in patients with schizophrenia who have gained weight during clozapine treatmentMary C Borovicka, Matthew A Fuller, P Eric Konicki, et al.
CNS Spectrums|July 27, 2005
Reassessing carbamazepine in the treatment of bipolar disorder: clinical implications of new dataHagop S Akiskal, Matthew A Fuller, Robert M A Hirschfeld, et al.
The Primary Care Companion for CNS Disorders|May 17, 2021
Development of Insomnia Associated With Different Formulations of BupropionKamal Gandotra, George E Jaskiw, Scott G Williams, et al.
Pageof 3